HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-dose prednisone therapy for infantile spasms and late-onset epileptic spasms in China: The addition of topiramate provides no benefit.

AbstractPURPOSE:
To compare the clinical efficacy of high-dose prednisone monotherapy and the combination of hormone and moderate-dose topiramate (TPM) therapy in children with infantile spasms (IS) and late-onset epileptic spasms (ES), and to evaluate whether the addition of TPM would provide more benefits for patients.
METHODS:
All patients were assigned to receive either high-dose prednisone alone (the maximum doses was 60 mg a day) or high-dose prednisone with TPM (the moderate doses was 5 mg/kg/day). The primary outcome was the proportion of children who achieved cessation of spasms at day-49 or day-56 after initial treatment (the minimum duration of treatment were 49 days).
RESULTS:
77 patients were randomly divided into two groups. The control rate of spasms on day-14 in hormone monotherapy was similar to combination therapy (71.8% vs 76.3%, p = 0.796). The cessation of spasms rate of patients on day-49 or day-56 was also similar between the two groups (71.8% vs 65.8%, p = 0.569). After 4 months, the cessation of spasms rate of patients in the group of hormone monotherapy was higher than the group of combination therapy, but there was no significant difference (61.5% vs 50.0%, p = 0.308).
CONCLUSION:
The efficacy of the combination therapy was not better than that of the monotherapy in achieving spasm freedom at 14-days, 49-days or 56-days and day-120 in the patients. Adding-on moderate-dose TPM did not help more children achieve spasm freedom and provided no benefit for prevention of IS and late-onset ES in short term. Higher-dose regimens of TPM might be more effective.
AuthorsZhaoshi Yi, Huaping Wu, Xiongying Yu, Jian Zha, Hui Chen, Yong Chen, Jianmin Zhong
JournalSeizure (Seizure) Vol. 71 Pg. 174-178 (Oct 2019) ISSN: 1532-2688 [Electronic] England
PMID31382136 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2019 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Anticonvulsants
  • Glucocorticoids
  • Topiramate
  • Prednisone
Topics
  • Age of Onset
  • Anticonvulsants (administration & dosage, pharmacology)
  • Child, Preschool
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids (administration & dosage, pharmacology)
  • Humans
  • Infant
  • Male
  • Outcome Assessment, Health Care
  • Prednisone (administration & dosage, pharmacology)
  • Spasms, Infantile (drug therapy)
  • Topiramate (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: